22Dec
Cadent Therapeutics Acquired by Novartis for Up to $770 Million
Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the treatment of cognitive, mood, and movement disorders, announced on December 17, 2020, that Novartis will acquire all of the outstanding capital stock of Cadent Therapeutics....
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
Jurisdictions Limiting Construction Work: Massachusetts: Construction generally is allowed in Massac...
Read More >
One new and different item laid out in the 2017 Evaluation, supplementing the Ten Hallmarks of an Ef...
Read More >
In recent times, energy efficiency has become a key priority for both public and private sector enti...
Read More >
On September 9, 2019, the Treasury Department (“Treasury”) and the Internal Revenue Service (the I...
Read More >
You’ve attended the webinars on navigating COVID-19. You’ve read the trade publication tips. You h...
Read More >
Seyfarth Synopsis: The Occupational Safety and Health Administration (OSHA) has issued an alert list...
Read More >